A scoping review to understand the indications, effectiveness, and limitations of cabergoline in radiological and biochemical remission of prolactinomas
Indian Journal of Endocrinology and Metabolism · 2021-11 · 25 (6) · 493-506
DOI: 10.4103/ijem.ijem_338_21 ↗Kurz gefasst
Scoping Review in der Zeitschrift Indian Journal of Endocrinology and Metabolism, online erschienen am 07.02.2022. Verfasst von Rakesh Mishra und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Cabergoline has long been used in the medical management of prolactin-secreting pituitary adenomas. However, there is contradicting and inadequate evidence on the efficacy of cabergoline in achieving radiological and biochemical remission in prolactinoma. This article presents scoping review of evidence in cabergoline achieving radiological and biochemical remission in cases of prolactinoma. We have used a recommended scoping review methodology to map and summarize existing research evidence and identify knowledge gaps. The review process was conducted according to the PRISMA-cR guidelines (Preferred Reporting Items for Systematic reviews and Meta-Analyses Extension for Scoping Reviews). The selection of studies was based on the criteria defined. Essential information such as reference details, study characteristics, topics of interest, main findings, and the study author's conclusion are presented in text and tables. With the study selection process, eight publications were finally included—one systematic review and meta-analysis, one RCT, and six primary studies. Cabergoline is effective in achieving biochemical and radiological remission in cases of prolactinoma. We identified several knowledge gaps with the scoping review and directions for future studies. Future studies, including randomized studies, will help address challenging questions associated with the management of prolactinoma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.
- Department of Neurosurgery, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, Karnataka, India.
- Department of Neurosurgery, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
Zitieren
APA
Mishra, R., Konar, S. K., Shrivastava, A., Chouksey, P., Raj, S., & Agrawal, A. (2021). A scoping review to understand the indications, effectiveness, and limitations of cabergoline in radiological and biochemical remission of prolactinomas. Indian Journal of Endocrinology and Metabolism, 25(6), 493-506. https://doi.org/10.4103/ijem.ijem_338_21
Vancouver
Mishra R, Konar SK, Shrivastava A, Chouksey P, Raj S, Agrawal A. A scoping review to understand the indications, effectiveness, and limitations of cabergoline in radiological and biochemical remission of prolactinomas. Indian Journal of Endocrinology and Metabolism. 2021;25(6):493-506. doi:10.4103/ijem.ijem_338_21
BibTeX
@article{Mishra2021,
author = {Mishra, Rakesh and Konar, Subhas K and Shrivastava, Adesh and Chouksey, Pradeep and Raj, Sumit and Agrawal, Amit},
title = {A scoping review to understand the indications, effectiveness, and limitations of cabergoline in radiological and biochemical remission of prolactinomas},
journal = {Indian Journal of Endocrinology and Metabolism},
year = {2021},
volume = {25},
number = {6},
pages = {493--506},
doi = {10.4103/ijem.ijem_338_21}
}
EUVIMED